Abstract
Pressman and Keighley1 demonstrated in 1948 that anti-kidney antibodies could be radio-labeled with 131I without loss of immunoreactivity, and when administered to an animal, localize renal tissue. In 1953, the same investigators detected a mouse osteo-sarcoma using radio-labeled anti-tumor antibodies.2 Since then, many reports have been published on uptake of radio-labeled anti-tumor antibodies in animal models.3–5
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pressman D, Keighley G. 1948. The zone of activity of antibodies as destermined by the use of radioactive tracers; the zone of activity of nephrotoxic antikidney serum. J Immunol 59:141–146.
Pressman D, Korngold L. 1953. The in vivo localization of anti-Wagner osteogenic sarcoma antibodies. Cancer 6:619–623.
Korngold L, Pressman D. 1954. The localization of anti-lymphosarcoma antibodies in the Murphy lymphosarcoma of the rat. Cancer Res 14:96–99.
Day ED, Planisek JA, Pressman D. 1960. Localization of radioiodinated antibodies in rats bearing tumors induced by N-2-Fluorenylacetamide. J Natl Cancer Inst 25:787–802.
Kyogoku M, Yagi Y, Planinsek J, Pressman D. 1964. Localizing properties of anti-rat hepatoma antibodies in vivo. Cancer Res 24:268–279.
Mach JP, Carrel S, Merenda C, et al. 1974. In vivo localization of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248:704–706.
Primus FJ, MacDonald R, Goldenberg DM, Hansen HJ. 1977. Localization of the W-39 tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. Cancer Res 37:1544–1547.
Belitsky P, Ghose T, Aguino J, et al. 1978. Radionuclide imaging of metastases from renal cell carcinoma by 131I-labeled anti-tumor antibody. Radiology 126:515–517.
Jaradpour N, Kim EE, DeLand FH, Salyer JP, Shah U, Goldenberg DM. 1981. The role of radioimmunodetection in the management of testicular cancer. J Am Med Assoc 246:45–49.
Koji T, Ishii T, Munehisa Y, et al. 1980. Localization of radioiodinated antibody to alpha feto protein. Antibody treatment of a hepatoma patient. Cancer Res 40:3013–3015.
Goldenberg DM, DeLand F, Kim E, et al. 1978. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photo-scanning. N Engl J Med 298:1384–1388.
Kim EE, DeLand FH, Casper S, et al. 1980. Radioimmunodetection of colorectal cancer. Cancer 45:1243–1247.
Van Nagell JR, Kim E, Casper S, et al. 1980. Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen. Cancer Res 40:502–506.
Mach JP, Carrel S, Forni M, et al. 1980. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 303:5–10.
Kohler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predetermined specificity. Nature 256:495–497.
Farrands PA, Pimm MV, Embleton MJ, et al. 1982. Radioimmunodetection of human colorectal cancers by an antitumour monoclonal antibody. Lancet 2:8295–8298.
Mach JP, Buchegger F, Forni M, et al. 1981. Use of radio-labelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2:239–249, 1981.
Delaloye B, Bischof-Delaloye A, Grob JPh, Buchegger F, Halpern S, Fliedner VV, Mach JP. 1984. SPECT with 1–123 labeled F(ab)2 fragments from monoclonal antibodies in colon carcinoma. J Nucl Med 25:1–17.
Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom I, Hellstrom KE. 1983. Imaging of melanoma with I-131-labeled monoclonal antibodies. J Nucl Med 24:123–129.
Larson SM. Personal Communication.
Halpern S, Stern P, Hagan P, et al. 1983. The labeling of monoclonal antibodies with 131Indium: technique and advantages compared to radioiodine labeling. In: Burchiel and Rhodes (ed). Elsevier Press, pp 197–205.
Sullivan DC, Silva JS, Cox CE, et al. 1982. Localization of I-131 labeled goat and primate anti carcinoembryonic antigen (CEA) antibodies in patients with cancer. Invest Radiol 17:350–355.
Halpern SE, Hagan PL., Garver PR, et al. 1983. Stability, characterization and kinetics of 111In-labeled monoclonal antibodies in normal animals and nude mouse-human tumor models. Cancer Res 43:5347–5355.
Halpern SE, Dillman RO, Hagan PL. 1983. The problems and promise of monoclonal antitumor antibodies. Diag Imag 5:47–49.
Krejcarek GE, Tucker KL. 1977. Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Com 77:581–585.
Dillman RO, Beauregard JC, Sobol RE, Royston I, Bartholomew RM, Hagan PL, Halpern SE. 1984. Lack of radioimmunodetection and complications associated with monoclonal anticarcino-embryonic antigen antibody cross-reactivity with an antigen on circulating cells. Cancer Res 44;2214–2218.
Dillman RO, Shawler DL, Dillman JB, Royston I. 1984. Therapy of chronic leukemia and cutaneous T-cell lymphoma with T-101 monoclonal antibody. J Clin Oncol 2:881–891.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Halpern, S.E., Dillman, R.O. (1985). Use of Radio-Labeled Antibodies in Diagnosis and Staging of Solid Tumors. In: Pattengale, P.K., Lukes, R.J., Taylor, C.R. (eds) Lymphoproliferative Diseases: Pathogenesis, Diagnosis, Therapy. Developments in Oncology, vol 31. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5016-0_10
Download citation
DOI: https://doi.org/10.1007/978-94-009-5016-0_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8721-6
Online ISBN: 978-94-009-5016-0
eBook Packages: Springer Book Archive